Recently, our group published evidence for a novel role of RAD51AP1 in lung and ovarian cancers, with up-regulation of RAD51AP1 in patient tissue and blood samples compared to control samples at mRNA level [3]. The gene discussed is RAD51AP1; the disease is ovarian carcinoma.